医学
外周穿刺中心静脉导管
导管
荟萃分析
中性粒细胞减少症
梅德林
重症监护医学
中心线
风险因素
菌血症
外科
内科学
抗生素
化疗
政治学
法学
生物
微生物学
作者
Bruna Salgado Rabelo,Kevin Augusto Farias de Alvarenga,Jhon Wesley Fernandes Bragança Miranda,Thales Pardini Fagundes,Camila Silva Peres Cancela,Roberta Maia de Castro Romanelli,Karla Emília de Sá Rodrigues
标识
DOI:10.1016/j.ajic.2022.05.005
摘要
Rationale
To understand the risk factors for catheter-related infection during treatment of pediatric cancer is essential to implement measures to prevent its occurrence. Objective
We performed a comprehensive systematic review of the literature with meta-analysis to identify and synthesize the main risk factors for catheter-related infection in children undergoing oncological treatment. Methods
Systematic searches were conducted in Medline, Embase, Lilacs, and BVS (Biblioteca Virtual em Saúde) until January 2022, following PRISMA guidelines. The search was not limited to language or dates. Risk factors were divided into host-related, assistance-related, and catheter types. We also describe the most common pathogens. Results
Thirteen studies were included in the review. Diagnosis of hematological neoplasm, the intensity of treatment, blood transfusion in the 4-7 days before the infection, type of long-term catheters (tunneled externalized catheters, double lumen, greater diameter), inpatient treatment, and a longer period of hospitalization were the most consistent risk factors. Metanalysis showed that neutropenia at the moment of catheter placement is not a risk factor for central-line-associated bloodstream infections, however, there is high heterogeneity between studies. Staphylococcus epidermidis was the most common pathogen reported. Conclusions
Understanding risk factors is an essential step to reduce morbidity and mortality of catheter-related infection. Education for preventive measures, reduction of hospitalization, wisely choosing the most adequate type of catheter, and the best moment for catheter insertion may reduce the occurrence of catheter-related infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI